Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Cited by
Items 101–200 of 1,013
Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus
Waterland, R. A., Lin, J.-R., Smith, C. A., & Jirtle, R. L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi484 · Cited by 337
Epigenetic Regulation by Histone Methylation and Histone Variants
Cheung, P., & Lau, P. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0496 · Cited by 330
Nimer, S. D. (2008) · Blood · doi:10.1182/blood-2007-08-078139 · Cited by 336
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
Chen, A.-N., Luo, Y., Yang, Y.-H., Fu, J.-T., Geng, X.-M., Shi, J.-P., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688910 · Cited by 324
Epigenetics—An Epicenter of Gene Regulation: Histones and Histone‐Modifying Enzymes
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461346 · Cited by 316
The effects of diabetes on male fertility and epigenetic regulation during spermatogenesis
Huang, H.-F., Ding, G.-L., Liu, Y., Liu, M.-E., Pan, J.-X., Guo, M.-X., & Sheng, J.-Z. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.150844 · Cited by 315
Yauk, C., Polyzos, A., Rowan-Carroll, A., Somers, C. M., Godschalk, R. W., Van Schooten, F. J., Berndt, M. L., Pogribny, I. P., Koturbash, I., Williams, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705896105 · Cited by 312
Epigenetics, spermatogenesis and male infertility
Rajender, S., Avery, K., & Agarwal, A. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.04.002 · Cited by 305
DNA Methylation as a Therapeutic Target in Cancer
Issa, J.-P. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2076 · Cited by 301
MicroRNA epigenetic signatures in human disease
Piletič, K., & Kunej, T. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1815-7 · Cited by 300
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
Wouters, B. J., & Delwel, R. (2016) · Blood · doi:10.1182/blood-2015-07-604512 · Cited by 292
Assessing the Effects of High Methionine Intake on DNA Methylation
Waterland, R. A. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1706s · Cited by 294
Scherrer, U., Rimoldi, S. F., Rexhaj, E., Stuber, T., Duplain, H., Garcin, S., de Marchi, S. F., Nicod, P., Germond, M., Allemann, Y., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.071183 · Cited by 295
Role of Epigenetics in Biology and Human Diseases.
Moosavi, A., & Ardekani, A. M. (2016) · PubMed · doi:10.22045/ibj.2016.01 · Cited by 273
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Herceg, Z., & Hainaut, P. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.01.004 · Cited by 282
The Roles of ROS in Cancer Heterogeneity and Therapy
de Sá Junior, P. L., Câmara, D. A. D., Porcacchia, A. S., Fonseca, P. M. M., Jorge, S. D., Araldi, R. P., & Ferreira, A. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2467940 · Cited by 287
Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development
Glaser, S., Schaft, J., Lubitz, S., Vintersten, K., van der Hoeven, F., Tufteland, K. R., Aasland, R., Anastassiadis, K., Ang, S.-L., & Stewart, A. F. (2006) · Development · doi:10.1242/dev.02302 · Cited by 289
Transgenerational Epigenetic Programming of the Brain Transcriptome and Anxiety Behavior
Skinner, M. K., Anway, M. D., Savenkova, M. I., Gore, A. C., & Crews, D. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003745 · Cited by 293
Rationally Engineered Nucleic Acid Architectures for Biosensing Applications
Xiao, M., Lai, W., Man, T., Chang, B., Li, L., Chandrasekaran, A. R., & Pei, H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00121 · Cited by 290
Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma
Jiang, S., Postovit, L., Cattaneo, A., Binder, E. B., & Aitchison, K. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00808 · Cited by 288
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
BackgroundIssa, J.-P. J., Gharibyan, V., Cortes, J., Jelinek, J., Morris, G., Verstovsek, S., Talpaz, M., Garcia-Manero, G., & Kantarjian, H. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.981 · Cited by 288
Xu, Q., Jiang, Y., Yin, Y., Li, Q., He, J., Jing, Y., Qi, Y.-T., Xu, Q., Li, W., Lu, B., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs049 · Cited by 285
Rauch, T., Wang, Z., Zhang, X., Zhong, X., Wu, X., Lau, S. K., Kernstine, K. H., Riggs, A. D., & Pfeifer, G. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701059104 · Cited by 287
Rethinking Periodontal Inflammation
Offenbacher, S., Barros, S. P., & Beck, J. D. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080220 · Cited by 279
McGarvey, K. M., Fahrner, J. A., Greene, E., Martens, J., Jenuwein, T., & Baylin, S. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2481 · Cited by 286
Watson, C. J., Collier, P., Tea, I., Neary, R., Watson, J. A., Robinson, C., Phelan, D., Ledwidge, M. T., McDonald, K. M., McCann, A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt614 · Cited by 278
Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation
McDonald, J. I., Celik, H., Rois, L. E., Fishberger, G., Fowler, T., Rees, R., Kramer, A., Martens, A., Edwards, J. R., & Challen, G. A. (2016) · Biology Open · doi:10.1242/bio.019067 · Cited by 275
Epigenetic Silencing of the PTEN Gene in Melanoma
Mirmohammadsadegh, A., Marini, A., Nambiar, S., Hassan, M., Tannapfel, A., Ruzicka, T., & Hengge, U. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0384 · Cited by 279
Peripheral nerve injury and myelination: Potential therapeutic strategies
Modrak, M., Talukder, M. A. H., Gurgenashvili, K., Noble, M., & Elfar, J. C. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24538 · Cited by 266
Nutritional Epigenomics of Metabolic Syndrome
Gallou-Kabani, C., & Junien, C. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1899 · Cited by 272
Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis
Bure, I. V., Nemtsova, M. V., & Kuznetsova, E. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105801 · Cited by 253
Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells
Saito, Y., & Jones, P. M. (2006) · Cell Cycle · doi:10.4161/cc.5.19.3340 · Cited by 270
Self-citationDuan, X., Liu, L., Feng, F., & Wang, S. (2010) · Accounts of Chemical Research · doi:10.1021/ar9001813 · Cited by 273
Prevention and treatment of drug addiction by environmental enrichment
Solinas, M., Thiriet, N., Chauvet, C., & Jaber, M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.08.002 · Cited by 253
Epigenetic Regulation of Neural Gene Expression and Neuronal Function
Feng, J., Fouse, S., & Fan, G. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180457635 · Cited by 261
Kim, Y.-I. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.11.2703 · Cited by 265
Cancer Epigenetics: Modifications, Screening, and Therapy
Einav Nili, G.-Y., Saito, Y., Egger, G., & Jones, P. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061606.095816 · Cited by 270
Self-citationDNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia
Yang, A. S., Doshi, K. D., Choi, S.-W., Mason, J. B., Mannari, R. K., Gharybian, V., Luna, R., Rashid, A., Shen, L., Estecio, M. R. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2385 · Cited by 266
Hiraga, J., Tomita, A., Sugimoto, T., Shimada, K., Ito, M., Nakamura, S., Kiyoi, H., Kinoshita, T., & Naoe, T. (2009) · Blood · doi:10.1182/blood-2008-08-175208 · Cited by 257
Al-Mahdawi, S., Pinto, R. M., Ismail, O., Varshney, D., Lymperi, S., Sandi, C., Trabzuni, D., & Pook, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm346 · Cited by 254
Epigenetic regulation of Keap1-Nrf2 signaling
Guo, Y., Yu, S., Zhang, C., & Kong, A.-N. T. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.013 · Cited by 258
Functional Role of G9a Histone Methyltransferase in Cancer
Casciello, F., Windloch, K., Gannon, F., & Lee, J. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00487 · Cited by 246
Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs)
Rochette-Egly, C., & Germain, P. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07005 · Cited by 243
Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Li, Y., & Tollefsbol, T. O. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791299966 · Cited by 255
Veeck, J., Niederacher, D., An, H., Klopocki, E., Wiesmann, F., Betz, B., Galm, O., Camara, O., Dürst, M., Kristiansen, G., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209386 · Cited by 254
Histone Modifications and Cancer
(2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60003-4 · Cited by 229
The Molecular Neurobiology of Depression
Shelton, R. C. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.12.005 · Cited by 243
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Hardie, W. D., Glasser, S. W., & Hagood, J. S. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081170 · Cited by 240
Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer
Hashimoto, Y., Akiyama, Y., & Yuasa, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062589 · Cited by 234
DNA demethylation in hormone-induced transcriptional derepression
Kim, M.-S., Kondo, T., Takada, I., Youn, M.-Y., Yamamoto, Y., Takahashi, S., Matsumoto, T., Fujiyama, S., Shirode, Y., Yamaoka, I., et al. (2009) · Nature · doi:10.1038/nature08456 · Cited by 236
RetractedTargeting histone deacetylase in cancer therapy
Lin, H., Chen, C., Lin, S., Weng, J., & Chen, C. (2006) · Medicinal Research Reviews · doi:10.1002/med.20056 · Cited by 241
Lee, H., Zhang, P., Herrmann, A., Yang, C., Xin, H., Wang, Z., Hoon, D. S. B., Forman, S. J., Jove, R., Riggs, A. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205132109 · Cited by 234
Causes of genome instability: the effect of low dose chemical exposures in modern society
Langie, S. A. S., Koppen, G., Desaulniers, D., Al-Mulla, F., Al-Temaimi, R., Amedei, A., Azqueta, A., Bisson, W. H., Brown, D., Brunborg, G., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv031 · Cited by 209
Genetic advances in sarcomeric cardiomyopathies: state of the art
Ho, C. Y., Charron, P., Richard, P., Girolami, F., Van Spaendonck-Zwarts, K. Y., & Pinto, Y. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv025 · Cited by 234
Li, M., Riddle, S. R., Frid, M. G., El Kasmi, K. C., McKinsey, T. A., Sokol, R. J., Strassheim, D., Meyrick, B., Yeager, M. E., Flockton, A. R., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100479 · Cited by 239
“In the current study, PH-Fibs, isolated from severely hypertensive animals, were found to exhibit significantly elevated catalytic activity of HDACs, a family of enzymes that are known to play critical roles in the control of epigenetics (53).”
Cancer biomarkers - current perspectives.
Bhatt, A. N., Mathur, R., Farooque, A., Verma, A., & Dwarakanath, B. S. R. (2010) · PubMed · Cited by 323
Rohde, C., Zhang, Y., Reinhardt, R., & Jeltsch, A. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-230 · Cited by 238
“DNA methylation is an essential process and abnormal methylation is associated with human diseases such as cancer [5,6].”
BackgroundAcute Myeloid Leukemia and Myelodysplastic Syndromes in Older Patients
Estey, E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2731 · Cited by 235
Trials with ‘epigenetic’ drugs: An update
Nebbioso, A., Carafa, V., Benedetti, R., & Altucci, L. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.004 · Cited by 237
“…insofar as it represents an important tool to advance our understanding of pathogenesis, in particular tumorigene- sis, and to help in the development (Egger et al., 2004; Strahl and Allis, 2000) of strategies for cancer treatment and prevention. niversit a degli Studi di Napoli, Vico L. de…”
BackgroundEpigenetics and cancer treatment
Kristensen, L. S., Nielsen, H. M., & Hansen, L. L. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.011 · Cited by 230
Epigenetics as a mechanism driving polygenic clinical drug resistance
Glasspool, R. M., Teodoridis, J. M., & Brown, R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603024 · Cited by 236
“Changes in cell metabolism (Paz et al 2002), “epigenetic drift”(Egger et al 2004) and aging (Richardson 2002) have all been proposed.”
Backgroundvan Doorn, R., Zoutman, W. H., Dijkman, R., de Menezes, R. X., Commandeur, S., Mulder, A. A., van der Velden, P. A., Vermeer, M. H., Willemze, R., Yan, P. S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.353 · Cited by 228
Chen, C.-S., Weng, S.-C., Tseng, P.-H., Lin, H.-P., & Chen, C.-S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505733200 · Cited by 231
lncRNAs: Insights into their function and mechanics in underlying disorders
Li, X., Wu, Z., Fu, X., & Han, W. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.04.002 · Cited by 232
Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
Wang, J., Wang, F., Mai, D., & Qu, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.585584 · Cited by 227
The sperm epigenome and potential implications for the developing embryo
Jenkins, T. G., & Carrell, D. T. (2012) · Reproduction · doi:10.1530/rep-11-0450 · Cited by 232
“In addition to studies using targeted genetic approaches in the study of DNA methylation are those using 5-azacytidine and 5-aza-2-deoxycytidine, both potent DNA methylation inhibitors (Egger et al. 2004).”
BackgroundEpigenetics of cervical cancer. An overview and therapeutic perspectives
Dueñas-González, A., Lizano, M., Candelaria, M., Cetina, L., Arce, C., & Cervera, E. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-38 · Cited by 231
Diabetic kidney diseases revisited: A new perspective for a new era
Fu, H., Liu, S., Bastacky, S. I., Wang, X., Tian, X.-J., & Zhou, D. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.005 · Cited by 226
Accuracy of DNA methylation pattern preservation by the Dnmt1 methyltransferase
Goyal, R. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl002 · Cited by 220
Wilson, A. G. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080172 · Cited by 224
Myofibroblast differentiation and survival in fibrotic disease
Kis, K., Liu, X., & Hagood, J. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001967 · Cited by 224
Azacytidine Inhibits RNA Methylation at DNMT2 Target Sites in Human Cancer Cell Lines
Schaefer, M., Hagemann, S., Hanna, K., & Lyko, F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0458 · Cited by 218
The fundamental role of epigenetics in hematopoietic malignancies
Galm, O., Herman, J. G., & Baylin, S. B. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.01.006 · Cited by 230
Chromatin remodeling in neural development and plasticity
Hsieh, J., & Gage, F. H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.002 · Cited by 228
Appleton, K., Mackay, H. J., Judson, I., Plumb, J. A., McCormick, C., Strathdee, G., Lee, C., Barrett, S., Reade, S., Jadayel, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8688 · Cited by 228
Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials
Ma, X., Ezzeldin, H. H., & Diasio, R. B. (2009) · Drugs · doi:10.2165/11315680-000000000-00000 · Cited by 227
“Chromosomal translocation of p300, CBP andMOZ genes have been reported in leukaemia,([20-22]) such that the HAT gene might insert into other genes to form a fusion protein, recruiting HAT to specific genes and resulting in the activation of these genes.([23])”
Ramazi, S., Allahverdi, A., & Zahiri, J. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00099-2 · Cited by 217
Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine
Liu, M., Ohtani, H., Zhou, W., Ørskov, A. D., Charlet, J., Zhang, Y. W., Shen, H., Baylin, S. B., Liang, G., Grønbæk, K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612262113 · Cited by 225
Self-citationDNA hypomethylation in the origin and pathogenesis of human diseases
Pogribny, I. P., & Beland, F. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0015-5 · Cited by 220
Song, Y., Ji, D., Li, S., Wang, P., Li, Q., & Xiang, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041274 · Cited by 223
DNA methyltransferases and epigenetic regulation in bacteria
Adhikari, S., & Curtis, P. D. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw023 · Cited by 217
DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy
Zhang, J., Yang, C., Wu, C., Cui, W., & Wang, L. (2020) · Cancers · doi:10.3390/cancers12082123 · Cited by 208
The Epigenetic Face of Systemic Lupus Erythematosus
Ballestar, E., Esteller, M., & Richardson, B. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7143 · Cited by 225
“Moreover, recent findings have indicated that epigenetic alterations accumulate gradually over an individual’s lifetime (14, 15).”
BackgroundEpigenetic mechanisms as a new approach in cancer treatment: An updated review
Fardi, M., Solali, S., & Farshdousti Hagh, M. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.06.003 · Cited by 209
Anzalone, A. A., Lettini, L., Fonsatti, E., & Maio, M. (2005) · The Women s Oncology Review · doi:10.3109/14733400500093346 · Cited by 222
Lin, R.-K., Hsieh, Y.-S., Lin, P., Hsu, H.-S., Chen, C.-Y., Tang, Y.-A., Lee, C.-F., & Wang, Y.-C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40706 · Cited by 219
Anzalone, A. A., Lettini, L., Fonsatti, E., & Maio, M. (2005) · The Women s Oncology Review · doi:10.1080/14733400500093346 · Cited by 221
Pai, A. A., Bell, J. T., Marioni, J. C., Pritchard, J. K., & Gilad, Y. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001316 · Cited by 208
HDAC inhibitors as anti‐inflammatory agents
Adcock, I. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707166 · Cited by 216
Chuang, J. C., Yoo, C. B., Kwan, J. M., Li, T. W. H., Liang, G., Yang, A. S., & Jones, P. A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0172 · Cited by 210
Self-citationEpigenetics and its role in male infertility
Dada, R., Kumar, M., Jesudasan, R., Fernández, J. L., Gosálvez, J., & Agarwal, A. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9715-0 · Cited by 206
Karahoca, M., & Momparler, R. L. (2013) · Clinical Epigenetics · doi:10.1186/1868-7083-5-3 · Cited by 213
The role of miRNA-29 family in cancer
Wang, Y., Zhang, X., Li, H., Yu, J., & Ren, X. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.11.004 · Cited by 209
Methyl-DNA Immunoprecipitation (MeDIP): Hunting down the DNA Methylome
Jacinto, F. V., Ballestar, E., & Esteller, M. (2008) · BioTechniques · doi:10.2144/000112708 · Cited by 214
Complex networks of multiple factors in the pathogenesis of uterine leiomyoma
Islam, M. S., Protic, O., Stortoni, P., Grechi, G., Lamanna, P., Petraglia, F., Castellucci, M., & Ciarmela, P. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.03.007 · Cited by 212
The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease
Roberts, T. C., Morris, K. V., & Wood, M. J. A. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0507 · Cited by 206
Chromatin structure and epigenetics
Quina, A. S., Buschbeck, M., & Di Croce, L. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.016 · Cited by 200
Epigenetic regulation of airway inflammation
Adcock, I. M., Tsaprouni, L., Bhavsar, P., & Ito, K. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.016 · Cited by 207
Role of Nucleosomal Occupancy in the Epigenetic Silencing of the MLH1 CpG Island
Lin, J. C., Jeong, S., Liang, G., Takai, D., Fatemi, M., Tsai, Y. C., Egger, G., Gal-Yam, E. N., & Jones, P. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.014 · Cited by 206
Self-citationPutnam, H. M., Davidson, J. M., & Gates, R. D. (2016) · Evolutionary Applications · doi:10.1111/eva.12408 · Cited by 206
“…to facilitate rapid beneficial acclimatization (Huey et al. 1999; Wilson and Franklin 2002) and is gaining attention across taxa from humans (Egger et al. 2004) to plants (Rapp and Wendel 2005) is epigenetics, or the heritable postsynthesis modification of DNA or DNA-associated proteins,…”
Background
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.